BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leiva-Juarez MM, Kirkpatrick CT, Gilbert BE, Scott B, Tuvim MJ, Dickey BF, Evans SE, Markesich D. Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir. Eur J Pharmacol 2018;818:191-7. [PMID: 29066417 DOI: 10.1016/j.ejphar.2017.10.035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Bordin AI, Cohen ND, Giguère S, Bray JM, Berghaus LJ, Scott B, Johnson R, Hook M. Host-directed therapy in foals can enhance functional innate immunity and reduce severity of Rhodococcus equi pneumonia. Sci Rep 2021;11:2483. [PMID: 33510265 DOI: 10.1038/s41598-021-82049-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Galeas-Pena M, McLaughlin N, Pociask D. The role of the innate immune system on pulmonary infections. Biol Chem 2019;400:443-56. [PMID: 29604208 DOI: 10.1515/hsz-2018-0304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
3 Reel JM, Lupfer CR. Sodium Pyruvate Ameliorates Influenza A Virus Infection In Vivo. Microbiology Research 2021;12:258-67. [DOI: 10.3390/microbiolres12020018] [Reference Citation Analysis]
4 Gonzalez AJ, Ijezie EC, Balemba OB, Miura TA. Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model. J Virol 2018;92:e00881-18. [PMID: 30232180 DOI: 10.1128/JVI.00881-18] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
5 Seo SU, Seong BL. Prospects on Repurposing a Live Attenuated Vaccine for the Control of Unrelated Infections. Front Immunol 2022;13:877845. [PMID: 35651619 DOI: 10.3389/fimmu.2022.877845] [Reference Citation Analysis]
6 Georgel AF, Cayet D, Pizzorno A, Rosa-Calatrava M, Paget C, Sencio V, Dubuisson J, Trottein F, Sirard JC, Carnoy C. Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir. Antiviral Res 2019;168:28-35. [PMID: 31078648 DOI: 10.1016/j.antiviral.2019.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Banerjee S, Banerjee D, Singh A, Saharan VA. A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines. AAPS PharmSciTech 2022;23:95. [PMID: 35314902 DOI: 10.1208/s12249-022-02247-3] [Reference Citation Analysis]
8 Van Herck S, De Geest BG. Nanomedicine-mediated alteration of the pharmacokinetic profile of small molecule cancer immunotherapeutics. Acta Pharmacol Sin 2020;41:881-94. [PMID: 32451411 DOI: 10.1038/s41401-020-0425-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Colalto C. Volatile molecules for COVID-19: A possible pharmacological strategy? Drug Dev Res 2020. [PMID: 32779824 DOI: 10.1002/ddr.21716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rowe RK, Gill MA. Targeting Antiviral Pathways for Treatment of Allergic Diseases. Journal of the Pediatric Infectious Diseases Society 2018;7:S54-6. [DOI: 10.1093/jpids/piy110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Goldblatt DL, Flores JR, Valverde Ha G, Jaramillo AM, Tkachman S, Kirkpatrick CT, Wali S, Hernandez B, Ost DE, Scott BL, Chen J, Evans SE, Tuvim MJ, Dickey BF. Inducible epithelial resistance against acute Sendai virus infection prevents chronic asthma-like lung disease in mice. Br J Pharmacol 2020;177:2256-73. [PMID: 31968123 DOI: 10.1111/bph.14977] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
12 Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, Tiram G, Liubomirski Y, Satchi-Fainaro R. Immune-mediated approaches against COVID-19. Nat Nanotechnol 2020;15:630-45. [PMID: 32661375 DOI: 10.1038/s41565-020-0732-3] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 54.0] [Reference Citation Analysis]
13 Labetoulle R, Detoc M, Gagnaire J, Berthelot P, Pelissier C, Fontana L, Botelho-Nevers E, Gagneux-Brunon A. COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines. Expert Rev Vaccines 2020;19:937-47. [PMID: 33107353 DOI: 10.1080/14760584.2020.1843432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]